Tonix Pharmaceuticals Announces Research Collaboration to Develop Precision Medicine Techniques for COVID-19 Vaccines and Therapeutics

NEXT STORY
Vystar to Produce RxAir400 UV-C Light Air Purifiers with New Manufacturer
PREV STORY
Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Tonix Pharmaceuticals Reports Third Quarter 2016 Financial Results

NEW YORK, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), ...

author_avatar
NASDAQ Market News

Stemline Therapeutics Announces Oral Presentation of SL-401 Phase 2 BPDCN Data at the 2016 ASCO Annual Meeting

NEW YORK, April 25, 2016 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today ...

author_avatar
NASDAQ Market News

Crescendo Bioscience Announces Six Presentations at the American College of Rheumatology 2017 Annual Meeting

SALT LAKE CITY, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary ...

author_avatar
NASDAQ Market News